Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.
Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
Scope of the Report:
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies ab ...
Table of Contents
1 Market Overview
1.1 Clinical Mass Spectrometry Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Clinical Diagnostics
1.3.2 Clinical Research
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
22.214.171.124 United States Market States and Outlook (2014-2024)
126.96.36.199 Canada Market States and Outlook (2014-2024)
188.8.131.52 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
184.108.40.206 Germany Market States and Outlook (2014-2024)
220.127.116.11 France Market States and Outlook (2014-2024)
18.104.22.168 UK Market States and Outlook (2014-2024)
22.214.171.124 Russia Market States and Outlook (2014-2024)
126.96.36.199 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India ...